FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
Jefferies analyst Michael Yee raised the price target on Akero Therapeutics (NASDAQ: AKRO) to $75.00 (from $50.00) while maintaining a Buy rating.
The analyst comments "We raise our PT to $75 based on $5-6B cap or $2-3B+ clear oppty in NASH based on strong F4... More

